Good news: Asthma medicines for all

International Journal of Tuberculosis and Lung Disease

Volumn 14, Issue 5, 2010, Pages 524-

  Billo, Nils E ^a  

^a INTERNATIONAL UNION AGAINST TUBERCULOSIS AND LUNG DISEASE   (France)

Author keywords

[No Author keywords available]

Indexed keywords

BECLOMETASONE; CHLOROFLUOROCARBON;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ASTHMA; BENIN; EDITORIAL; EL SALVADOR; HUMAN IMMUNODEFICIENCY VIRUS; LOWEST INCOME GROUP; LUNG DISEASE; MEDICINE; PRIORITY JOURNAL; TUBERCULOSIS;

ANTI-ASTHMATIC AGENTS; ASTHMA; DELIVERY OF HEALTH CARE; DEVELOPING COUNTRIES; HEALTH KNOWLEDGE, ATTITUDES, PRACTICE; HUMANS;

EID: 77950899841     PISSN: 10273719     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Editorial

References (3)

1. Smith D H, Malone D C, Lawson K A, Okamoto L J, Battista C, Saunders W B. A national estimate of the economic costs of asthma. Am J Respir Crit Care Med 1997; 156: 787-793. (Pubitemid 27396416)
2. Billo N E. Asthma Drug Facility: from concept to reality. Int J Tuberc Lung Dis 2006; 10: 709.
3. Masoli M, Fabian D, Holt S, Beasley R; Global Initiative for Asthma (GINA) Program. The global burden of asthma: executive summary of the GINA Dissemination Committee report. Allergy 2004; 59: 469-478. (Pubitemid 38580764)